LOS ANGELES, Oct 6 (Reuters) - Gen-Probe Inc said on Tuesday it plans to acquire Prodesse Inc, a privately held provider of clinical tests for influenza and other infectious diseases, for around $60 ...

Hologic ($HOLX) will become a major player in molecular diagnostics focused on sexually transmitted diseases and boost its women's health expertise with the company's ...

Medical device maker Hologic Inc. has agreed to buy diagnostic test maker Gen-Probe Inc. for about $3.72 billion, expanding its portfolio in an area of medicine expected to see big growth. Gen-Probe ...

The test has been approved to run on Gen-Probe's fully automated, high-throughput TIGRIS instrument system. Unlike available DNA-based tests, the APTIMA HPV assay detects messenger RNA over-expressed ...

NEW YORK (AP) -- Medical device maker Hologic Inc. came a step closer to completing its $3.76 billion acquisition of diagnostic test maker Gen-Probe Inc. after it passed a regulatory bar. The ...

CHICAGO (Reuters) - Diagnostic test maker Gen-Probe Inc is again hunting for acquisition targets in Europe, two months after walking away from a proposed $335 million takeover of Innogenetics NV , its ...

announced today that the Company has acquired GTI Diagnostics, a privately held specialty diagnostics company focused on the transplantation, blood bank and specialty coagulation markets, for $53 ...

ProFlu-ST is cleared for use until April 26, 2010. Gen-Probe has been granted an EUA (emergency use authorization) for the Prodesse ProFlu-ST™ to be used in CLIA high-complexity laboratories for ...

Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the ...